Journal of Applied Physiology Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 101: 506-511, 2006. First published April 20, 2006; doi:10.1152/japplphysiol.01558.2005
8750-7587/06 $8.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
101/2/506    most recent
01558.2005v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gatti, R.
Right arrow Articles by Trevisani, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gatti, R.
Right arrow Articles by Trevisani, M.

Protease-activated receptor-2 activation exaggerates TRPV1-mediated cough in guinea pigs

Raffaele Gatti,1 Eunice Andre,1 Silvia Amadesi,3 Thai Q. Dinh,4 Axel Fischer,4 Nigel W. Bunnett,3 Selena Harrison,2 Pierangelo Geppetti,1,2 and Marcello Trevisani1

1Center of Excellence for the Study of Inflammation, University of Ferrara, Ferrara; 2Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy; 3Departments of Surgery and Physiology, University of California, San Francisco, California; and 4Allergie-Zentrum Charité, Charité-Universitätsmedizin Berlin, Berlin, Germany

Submitted 12 December 2005 ; accepted in final form 6 April 2006

A lowered threshold to the cough response frequently accompanies chronic airway inflammatory conditions. However, the mechanism(s) that from chronic inflammation results in a lowered cough threshold is poorly understood. Irritant agents, including capsaicin, resiniferatoxin, and citric acid, elicit cough in humans and in experimental animals through the activation of the transient receptor potential vanilloid 1 (TRPV1). Protease-activated receptor-2 (PAR2) activation plays a role in inflammation and sensitizes TRPV1 in cultured sensory neurons by a PKC-dependent pathway. Here, we have investigated whether PAR2 activation exaggerates TRPV1-dependent cough in guinea pigs and whether protein kinases are involved in the PAR2-induced cough modulation. Aerosolized PAR2 agonists (PAR2-activating peptide and trypsin) did not produce any cough per se. However, they potentiated citric acid- and resiniferatoxin-induced cough, an effect that was completely prevented by the TRPV1 receptor antagonist capsazepine. In contrast, cough induced by hypertonic saline, a stimulus that provokes cough in a TRPV1-independent manner, was not modified by aerosolized PAR2 agonists. The PKC inhibitor GF-109203X, the PKA inhibitor H-89, and the cyclooxygenase inhibitor indomethacin did not affect cough induced by TRPV1 agonists, but abated the exaggeration of this response produced by PAR2 agonists. In conclusion, PAR2 stimulation exaggerates TRPV1-dependent cough by activation of diverse mechanism(s), including PKC, PKA, and prostanoid release. PAR2 activation, by sensitizing TRPV1 in primary sensory neurons, may play a role in the exaggerated cough observed in certain airways inflammatory diseases such as asthma and chronic obstructive pulmonary disease.

citric acid; protein kinase; resiniferatoxin; hypertonic saline; indomethacin; transient receptor potential vanilloid 1


Address for reprint requests and other correspondence: M. Trevisani, Center of Excellence for the study of Inflammation, Dept. of Clinical & Experimental Medicine, Pharmacology Section, Univ. of Ferrara, 44100 Ferrara, Italy (e-mail: tvm{at}unife.it)




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
M.-H. Kim, B.-H. Choi, S.-R. Jung, T. J. Sernka, S. Kim, K.-T. Kim, B. Hille, T. D. Nguyen, and D.-S. Koh
Protease-activated Receptor-2 Increases Exocytosis via Multiple Signal Transduction Pathways in Pancreatic Duct Epithelial Cells
J. Biol. Chem., July 4, 2008; 283(27): 18711 - 18720.
[Abstract] [Full Text] [PDF]

Home page
 Chronic Respiratory DiseaseHome page
L.P.A. McGarvey, L. Polley, and J. MacMahon
Review Series: Chronic cough: Common causes and current guidelines
Chronic Respiratory Disease, November 1, 2007; 4(4): 215 - 223.
[Abstract] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. Bhattacharya, B. P. Scott, N. Nasser, H. Ao, M. P. Maher, A. E. Dubin, D. M. Swanson, N. P. Shankley, A. D. Wickenden, and S. R. Chaplan
Pharmacology and Antitussive Efficacy of 4-(3-Trifluoromethyl-pyridin-2-yl)-piperazine-1-carboxylic Acid (5-Trifluoromethyl-pyridin-2-yl)-amide (JNJ17203212), a Transient Receptor Potential Vanilloid 1 Antagonist in Guinea Pigs
J. Pharmacol. Exp. Ther., November 1, 2007; 323(2): 665 - 674.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.